Technical Analysis

Stock query: Strides Pharma in a consolidation phase

Yoganand D | Updated on March 15, 2020 Published on March 15, 2020

A decisive fall below ₹340 can test the long-term support at ₹300

Here are the answers to readers’ queries on the performance of their stock holdings.

I am a long-term investor. Can you inform about the long- and medium-term prospects of Strides Pharma shares purchased at ₹497?. Shall I dispose the shares at the current rate and book losses?

S Vanaja

Strides Pharma Science (₹401): The stock of Strides Pharma Science has been in a wide sideways consolidation phase between ₹300 and ₹550 since May 2018. Within this consolidation phase, it encountered a key resistance at ₹550 in February 2020 and began to decline. The short-term trend is down.

The stock recently took a support at ₹340 and bounced up strongly, but faces a key hurdle at ₹460 and ₹475. A break above these levels can push it northwards to ₹500 and then to ₹550 in the medium term.

However, failure to move beyond ₹475 can keep the short-term downtrend intact and drag the stock lower to ₹360 and then to ₹340 once again. A decisive fall below ₹340 can test the long-term support at ₹300. You can consider averaging the stock declines with a long-term stop-loss at ₹280. An emphatic break above the crucial long-term resistance at ₹550 can take the stock higher to ₹600 and then to ₹700 over the long run.

To alter the long-term downtrend that has been in place since the stock recorded a new high at ₹1,371 in late 2015, it needs to conclusively break above ₹850 (this is a vital long-term resistance to be noted). In that case, the stock can trend upwards to ₹900 and ₹1000.

I bought shares of Siemens at ₹1,560. It has been declining continuously. Should I hold or exit?

Manish Saraogi

Siemens (₹1,212.3): The stock recorded an intra-week low at ₹1,030 and bounced up strongly. But it faces a key barrier at ₹1,310 with an immediate resistance at ₹1,250.

A decisive break above this level can pave the way for a corrective rally to ₹1,400.

The next resistance is at ₹1,450, which is a key trend-deciding level of the intermediate-term downtrend that has been in place since an all-time high of ₹1,716 registered in October 2019.

The subsequent resistance are at ₹1,500 and ₹1,600.

On the downside, a decisive plunge below the immediate support at ₹1,100 can strengthen the downtrend and pull the stock lower to ₹1,050 and then to ₹1,000 in the medium term.

You can wait and average the stock at lower levels with a stop-loss at ₹980.

Send your queries to

Published on March 15, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.